S&P 500   2,995.71 (+0.00%)
DOW   27,012.16 (-0.05%)
QQQ   193.34 (-0.09%)
AAPL   234.46 (-0.37%)
FB   188.69 (-0.11%)
MSFT   140.67 (-0.64%)
GOOGL   1,253.15 (+0.88%)
CGC   19.54 (-2.79%)
NVDA   198.77 (+1.22%)
BABA   175.87 (+0.33%)
TSLA   261.50 (+1.40%)
AMD   31.35 (+2.05%)
T   37.93 (+0.08%)
F   9.14 (+0.66%)
PRI   125.41 (+1.41%)
NFLX   284.22 (-0.01%)
BAC   30.46 (+2.46%)
GILD   65.54 (+0.37%)
DIS   130.87 (+0.86%)
S&P 500   2,995.71 (+0.00%)
DOW   27,012.16 (-0.05%)
QQQ   193.34 (-0.09%)
AAPL   234.46 (-0.37%)
FB   188.69 (-0.11%)
MSFT   140.67 (-0.64%)
GOOGL   1,253.15 (+0.88%)
CGC   19.54 (-2.79%)
NVDA   198.77 (+1.22%)
BABA   175.87 (+0.33%)
TSLA   261.50 (+1.40%)
AMD   31.35 (+2.05%)
T   37.93 (+0.08%)
F   9.14 (+0.66%)
PRI   125.41 (+1.41%)
NFLX   284.22 (-0.01%)
BAC   30.46 (+2.46%)
GILD   65.54 (+0.37%)
DIS   130.87 (+0.86%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Gemphire TherapeuticsMusclePharmPhio PharmaceuticalsReliv InternationalSynergy Pharmaceuticals
SymbolNASDAQ:GEMPOTCMKTS:MSLPNASDAQ:PHIONASDAQ:RELVN/A
Price Information
Current Price$0.36$0.52$0.20$4.43N/A
52 Week RangeBuyN/AN/AN/AHold
Analyst Ratings
Consensus RecommendationBuyN/AN/AN/AHold
Consensus Price TargetN/AN/AN/AN/AN/A
% Upside from Price TargetN/AN/AN/AN/AN/A
Trade Information
Market Cap$4.91 million$12.60 million$5.50 million$7.65 million$7.44 million
Beta2.862.051.670.224.94
Average Volume139,6722,771222,9892,2146,081,307
Sales & Book Value
Annual RevenueN/A$102.15 million$140,000.00$36.12 million$16.82 million
Price / SalesN/A0.0936.560.210.00
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.54 per share($0.86) per share$0.75 per share$6.50 per share($0.02) per share
Price / BookN/A-0.600.270.680.00
Profitability
Net Income$-23,640,000.00$-10,970,000.00$-7,360,000.00$-1,900,000.00$-224,330,000.00
EPSN/AN/A($1.04)N/A($1.02)
Trailing P/E Ratio0.000.00N/A0.00N/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/A-1.27%-332.11%
Return on Equity (ROE)-262.94%N/A-80.38%-3.75%N/A
Return on Assets (ROA)-120.26%N/A-65.68%-2.66%-118.14%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.05%0.01%N/A
Current Ratio1.95%N/A5.87%1.50%0.52%
Quick Ratio1.95%N/A5.87%0.89%0.38%
Ownership Information
Institutional Ownership Percentage21.03%27.84%5.27%8.21%28.47%
Insider Ownership Percentage22.70%60.70%1.01%31.18%4.80%
Miscellaneous
Employees9569156N/A
Shares Outstanding14.87 million17.38 million25.59 million1.75 million248.04 million
Next Earnings Date11/14/2019 (Estimated)11/12/2019 (Estimated)11/13/2019 (Estimated)11/8/2019 (Estimated)N/A
OptionableOptionableNot OptionableNot OptionableNot OptionableOptionable
 Gemphire TherapeuticsMusclePharmPhio PharmaceuticalsReliv InternationalSynergy Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel